FOLH1 and breast cancer: More recently, Heesch and colleagues performed an in vivo evaluation of [177Lu]Lu-PSMA-imaging I&T imaging and therapy in TN BC mice, comparing a single dose and a fractionated-dose approach, and observed that RLT could inhibit tumour growth and improve survival rates in the models acting as an anti-angiogenic radiotherapy [34].